Head and neck tumor cell radiation response occurs in the presence of IGF1

K. Victory, R. Burd, A. Fribley, S. Sittadjody, D. Arnett, R. R. Klein, K. H. Limesand

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Radiation therapy for head and neck cancer results in severe secondary side-effects in salivary glands. We previously demonstrated that the administration of IGF1 preserves or restores salivary gland function following radiation. Based on these findings, we propose to study the effect of IGF1 on human head and neck carcinoma cells. Head and neck tumor cells treated with radiation have significant reductions in tumor cell survival, as measured by MTT and crystal violet assays, regardless of IGF1 pre-treatment. Head and neck squamous carcinoma cell xenografts treated with concurrent radiation+IGF1 also exhibit significant tumor growth delay; however, growth rates are elevated compared with those in irradiated xenografts. In contrast, administration of IGF1 after radiation treatment has no effect on tumor xenograft growth rates. Analysis of these data suggests that localized delivery may be required for concurrent therapy to prevent secondary side-effects of radiotherapy, while post-therapy administration of IGF1 could be considered for the restoration of salivary function. Abbreviations: IGF1, insulin-like growth factor 1; MTT, 2,2,2-Tribromoethanol; CV, crystal violet; IGFR, insulin-like growth factor receptor; HN, head and neck.

Original languageEnglish (US)
Pages (from-to)347-352
Number of pages6
JournalJournal of Dental Research
Volume90
Issue number3
DOIs
StatePublished - Mar 1 2011

    Fingerprint

Keywords

  • IGF1
  • head and neck cancer
  • radiation

ASJC Scopus subject areas

  • Dentistry(all)

Cite this